Experience in Borderline Ovarian Tumors

University of Palermo

Status: Not yet enrolling

Conditions: Borderline Ovarian Tumor

Study type: Observational

Funder types: Other

Identifiers

NCT05791838

BOT-1

Details and patient eligibility

About

Borderline ovarian tumors (BOTs) comprise 15-20% of primary ovarian neoplasms and represent an independent disease entity among epithelial ovarian cancers. The present study aimed to report the 8-year experience of a single center on the management and outcomes of consecutive BOTs patients. From January 2010 to December 2017, all patients with BOTs undergoing surgical treatment were included. Demographic, clinical, and pathological data were reviewed retrospectively.

Enrollment: 86 estimated patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age > 18 years,
• Patients affected by borderline ovarian tumors (BOT) of any histological type and any FIGO stage,
• Women undergoing surgical treatment with both laparoscopic and laparotomic approaches.

Exclusion criteria

• Women affected by ovarian cancers